| mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.005 |
0.9 |